Friday, August 26, 2022 9:37:07 AM
"It is important for the United States to supply the market to support allies in Europe and Asia and improve the ability of the developing world to access gas," said Mike Sabel, Venture Global LNG's chief executive. His firm has entered into agreements to sell 18.5 MTPA of LNG since last September.
Some of the biggest deals are from Chinese firms returning to the U.S. market after a pause over tariff disputes. Late last year, Venture Global LNG struck deals for 11 MTPA with units of China's Sinopec and CNOOC Ltd. China's ENN Natural Gas Co signed separate deals last year with Cheniere Energy and Energy Transfer.
Due to the lack of available capacity, some recent deals have involved facilities whose construction have not yet received financial approvals. Those agreements "reinforce our conviction in the long-term role" for LNG in global energy markets, said Tim Wyatt, a Cheniere senior vice president.
For a factbox on recent North American LNG deals, see
But rising demand has led to construction of three new U.S. export projects and several more could be approved in 2023.
Recent LNG News
- Cheniere Reports First Quarter 2024 Results and Reconfirms Full Year 2024 Financial Guidance • Business Wire • 05/03/2024 11:30:00 AM
- Cheniere Declares Quarterly Dividend • Business Wire • 04/26/2024 12:30:00 PM
- Cheniere Announces Timing of First Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 01:00:53 PM
- Cheniere Announces Pricing of $1.5 Billion Senior Notes due 2034 • Business Wire • 03/05/2024 09:04:00 PM
- Cheniere Announces Offering of Senior Notes due 2034 • Business Wire • 03/05/2024 01:28:00 PM
- Cheniere Reports Fourth Quarter and Full Year 2023 Results and Introduces Full Year 2024 Financial Guidance • Business Wire • 02/22/2024 12:30:00 PM
- U.S. Futures Surge on Nvidia’s Stellar Performance, Global Markets Respond Positively • IH Market News • 02/22/2024 11:05:39 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM